nach oben

Der Nervenarzt

Erschienen in:

01.06.2009 | Aktuelles

Bericht vom NeuroUpdate der Med-Update-Reihe in Wiesbaden (13./14.02.09)

verfasst von: Prof. Dr. M. Dieterich, G. F. Hamann

Erschienen in: Der Nervenarzt | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Auszug

Am 13. und 14. Februar 2009 fand in Wiesbaden das 1. NeuroUpdate aus der Med-Update-Reihe unter der wissenschaftlichen Leitung von Prof. Dr. Marianne Dieterich, Ludwig-Maximilians-Universität München (LMU), und Prof. Dr. Gerhard F. Hamann, Horst Schmidt Kliniken (HSK) Wiesbaden, statt. …

Ambrosini A, Vandenheede M, Rossini P et al (2005) Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: A double-blind placebo-controlled study. Pain 118:92–96PubMedCrossRef

Beckett NS, Peters ChBR, Fletcher AE et al (2008) for the HYVET study group. Treatment of hypertension in patients 80 years of age and older. NEJM 358:1887–1898PubMedCrossRef

Birnbaum G, Cree B, Altafullah I et al (2008) Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. Neurology 71:1390–1395PubMedCrossRef

Cantani M, Mesulam M (2008) The arcuate fasciculus and the disconnection theme in language and aphasia: History and current state. Cortex 44:953–961CrossRef

Commission on Classification and Terminology of the International League against Epilepsy (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389–399CrossRef

Cooper M, Willingham DL, Brown DE et al (2007) Rituximab for the treatment of juvenile dermatomyositis. 56(9):993107–993111

de Gelder B, Tamietto M, van Boxtel G et al (2008) Intact navigation skills after bilateral loss of striate cortex. Curr Biol 18:1128–1129CrossRef

Dichgans M (2007) Genetics of ischaemic stroke. Lancet Neurol 6:149–161PubMedCrossRef

Dowson A, Mullen MJ, Peatfield R et al (2008) Migraine Intervention with STARFlex Technology (MIST) trial: A prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 117:1397–1404PubMedCrossRef

10.

Eggers J, Konig IR, Koch B et al (2008) Sonothrombolysis with transcranial color-coded sonography and recombinant tissue-type plasminogen activator in acute middle cerebral artery main stem occlusion: results from a randomized study. Stroke 39(5):1470–1475PubMedCrossRef

11.

Fahn S, Oakes D, Shoulson I et al (2004) Levodopa and the progression of Parkinson’s disease. N Engl J Med 351:2498–2508PubMedCrossRef

12.

Fallon BA, Keilp JG, Corbera KM et al (2008) A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 70:992–1003PubMedCrossRef

13.

Gaede P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580–591PubMedCrossRef

14.

Hacke W, Kaste M, Bluhmki E et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359(13):1317–1329PubMedCrossRef

15.

Hauser SL et al (2008) B-cell depletion with rituximab in relapsing remitting MS. N Engl J Med 358:676–688PubMedCrossRef

16.

Healey JS, Hart RS, Pogue J et al (2008) Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk. Stroke 39:1482–1486PubMedCrossRef

17.

Heckenberg SGB, de Gans J, Brouwer MC et al (2008) Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis. A prospective cohort study. Medicine (Baltimore) 87:185–192

18.

Herrlinger U, Rieger J, Koch D et al (2006) Phase II trial of lomustine plus temozolomide in addition to radiotherapy in newly diagnosed gliobastoma. JCO 24:4412–4417 und JCO 2009 in pressCrossRef

19.

Hohlfeld T, Zimmermann N, Weber AA et al (2008) Pyrazoline analgesics prevent the antiplatelet effect of aspirin and preserve human platelet thromboxane synthesis. J Thromb Haemost 6:166–173PubMed

20.

Holloway RG, Shoulson I, Fahn S et al (2004) Pramipexole vs levodopa as initial treatment for Parkinson disease: A 4-year randomized controlled trail. Arch Neurol 61:1044–1053PubMedCrossRef

21.

Houde S, Filiatrault M, Fournier A et al (2008) Deflazacort use in duchennne muscular dystrophy: An 8-year follow up. Pediatr Neurol 38:200–206PubMedCrossRef

22.

Illa I, Diaz-Manera J, Rojas-Garcia R et al (2008) Sustained response to rituximab in anti-AChR and anti-MuSK positive myasthenia gravis patients. J Neruoimmunology 201–202:90–94

23.

Hafler DA, Compston A, Sawcer S et al (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357:851–862PubMedCrossRef

24.

Jacob A, Weinshenker BG Violich I, McLinskey N et al (2008) Treatment of neuromyelitis optica with rituxiamb: Retrospective analysis of 25 patients. Arch Neurol 65:1443–1448PubMedCrossRef

25.

Koster-Rasmussen R, Korshin A, Meyer CM (2008) Antibiotic treatment delay and outcome in acute bacterial meningitis. J lnfection 57:449–454CrossRef

26.

Lautenschlager NT, Cox KL, Flicker L et al (2008) Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 300:1027–1037PubMedCrossRef

27.

Lossius Ml, Hessen E, Mowinckel P et al (2008) Consequences of antiepileptic drug with drawal: A randomized, double-blind study (Akershus Study). Epilepsia 49:455–463PubMedCrossRef

28.

Manlhoit C, Tyrrell P, Liang L et al (2008) Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: Adverse reactions are associated with Immunoglobulin a Content. Pediatrics 121:e626–e630CrossRef

29.

Mayer SA, Brun NC, Begtrup K et al (2008) Efficacy and safety of recombinant activated factor vii for acute intracerebral hemorrhage. N Engl J Med 358:2127–2137PubMedCrossRef

30.

Medina MT, Suzuki T, Alonso ME et al (2008) Novel mutations in Myoclonin1/EFHC1 in sporadic and familial juvenile myoclonic epilepsy. Neurology 70:2137–2144PubMedCrossRef

31.

Miller ER, 3rd Pastor-Barriuso R, Dalal D et al (2005) Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann intern Med 142:37–46PubMed

32.

Minagara A, Murray TJ (2008) PROOF Study Investigators. Efficacy and tolerability of intramuscular interferon beta-1a compared with subcutaneous interferon beta-1a in relapsing MS: Results from PROOF. Curr Med Res Opin 24:1049–1066PubMedCrossRef

33.

Mpimbaza A, Ndeezi G, Staedtke S et al (2008) Comparison of buccal midazolam with rectal diazepam in the treatment of prolonged seizures in Ugandan children: A randomized clinical trial. Pediatrics 121:e58–e64PubMedCrossRef

34.

Nath K, Agarwal M, Ramola M et al (2009) Role of diffusion tensor imaging metrics and in vivo proton magnetic resonance spectroscopy in the differential diagnosis of cystic intracranial mass lesions. Magnetic Resonance Imaging (in press)

35.

Norden AD, Young GS, Setayesh K et al (2008) Bevacizumab for recurrent malignant glioma. Neurology 70:779–787PubMedCrossRef

36.

Olanow CW, Hauser PA, Jankovic J et al (2008) A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson‘s disease (the ADAGIO study): rationale, design and baseline characteristics. Mov Disord 23:2194–12201PubMedCrossRef

37.

Poewe W, Luessi F (2005) Clinical studies with transdermal rotigotine in early Parkinson’s disease. Neurology 65:S11–S14PubMed

38.

Rascol O, Brooks DJ, Korczyn AD et al (2003) A five-year study of the incidence of dyskinesia in patients with early Parkinson‘s disease who were treated with ropinirole or levodopa. 056 Study Group. N Engl J Med 342:1484–1491CrossRef

39.

Richter M, Miltner WHR, StraubeT (2008) Association between therapy outcome and righthemispheric activation in chronic aphasia. Brain 131:1391–1401PubMedCrossRef

40.

Rolfs A, Böttcher T, Zschiesche M et al (2005) Prevalence of Farby disease in patients with cryptogenic stroke: A prospective study. Lancet 366:1794–1796PubMedCrossRef

41.

Rush AM, Dib-Hajj SD, Liu S et al (2006) A single sodium channel mutation produces hyper- or hypoexcitability in different types of neuroms. Proc Natal Acad Sci USA 103:8245–8250CrossRef

42.

Sacco RL, Diener HC, Yusuf S et al (2008) Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. NEJM 359:128–1251CrossRef

43.

Sillanpää M, Schmidt D (2008) Seizure clustering during drug treatment affects seizure outcome and mortality of childhood-onset epilepsy. Brain 131:938–944PubMedCrossRef

44.

Stocchi F, Hersh BP, Scott BL et al (2008) Ropinirole 24-hour prolonged release and ropinirole immediate release in early Parkinson‘s disease: A randomized, double-blind, non-inferiority crossover study. Curr Med Res Opin 24:2883–2895PubMedCrossRef

45.

Strupp M, Huppert D, Frenzel C (2008) Long-term prophylactic treatment of attacks of vertigo in Menière‘s disease – comparison of a high with a low dosage of betahistin in an open trial. Acta Otolaryngol (Stockh) 126:620–624

46.

Strupp M, Schüler O, Krafczyk S et al (2003)Treatment of downbeat nystagmus with 3,4-diaminopyridine-placebo-controlled study. Neurology 61:165–170PubMed

47.

Strupp M, Zingler VC, Arbusow V et al (2004) Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med 351:354–361PubMedCrossRef

48.

Sveen ML, Jeppesen TD, Hauerslev S et al (2008) Endurance training improves fitness and strength in patients with Becker muscular dystrophy. Rain 131:2824–2831

49.

Tariot PN, Farlow MR, Grossberg GT et al (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: A randomized controlled trial. JAMA 291:371–324

50.

The ONTARGET Investigators (2008) Telmisaran, Ramipril, or both in patients at high risk for vascular events. NEJM 358:1547–1559CrossRef

51.

Trikha I, Singh S, Goyal V et al (2007) Comparative efficacy of low dose, daily versus alternate day plasma exchange in severe myasthenia gravis. J Neurol 254:989–995PubMedCrossRef

52.

Vahedi K, Hofmeijer J, Juettler E et al (2007) Early decompressive surgery in malignant infarction of the middle cerebral artery: A pooled analysis of three randomised controlled trails. Lancet Neurol 6:215–222PubMedCrossRef

53.

Wahlgren N, Ahmed N, Davalos A et al (2008) Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): An observational study. Lancet 372 9646:1303–1309CrossRef

54.

Wick W, Weller M (2008) For the Neurooncology Working Group (NOA) of the German Cancer Society. Randomized phase –III study of sequential radiochemotherapy of oligoastrocytic tumors of WHO-grade III with PCV for temozolomide: NOA-04. JCO 26(15S):2008

55.

Yusuf M, Diener HC, Sacco RL et al (2008) Telmisartan to prevent recurrent stroke and cardiovascular events. EJM 359:1225–1237

56.

Zinman L, Ng E, Bril V (2007) Iv immunoglobulin in patients with myasthenia gravis: A randomized controlled trial. Neurology 68:837–841PubMedCrossRef

Titel: Bericht vom NeuroUpdate der Med-Update-Reihe in Wiesbaden (13./14.02.09)
verfasst von: Prof. Dr. M. Dieterich
G. F. Hamann
Publikationsdatum: 01.06.2009
Verlag: Springer-Verlag
Erschienen in: Der Nervenarzt / Ausgabe 6/2009
Print ISSN: 0028-2804
Elektronische ISSN: 1433-0407
DOI: https://doi.org/10.1007/s00115-009-2730-4

Neu in den Fachgebieten Neurologie und Psychiatrie

25.04.2024 | Hypotonie | Nachrichten

Springer Medizin

Bericht vom NeuroUpdate der Med-Update-Reihe in Wiesbaden (13./14.02.09)

Auszug

Neu in den Fachgebieten Neurologie und Psychiatrie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2009

Tiefe Hirnstimulation bei Dystonie

Tiefe Hirnstimulation bei essenziellem Tremor

Thymomassoziierte Polymyositis

Neurochirurgische Standards bei tiefer Hirnstimulation

Standards für die tiefe Hirnstimulation

Nachruf auf Prof. Dr. med. Hans Schliack

Neu in den Fachgebieten Neurologie und Psychiatrie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Weniger postpartale Depressionen nach Esketamin-Einmalgabe